BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 13678417)

  • 1. Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.
    Aiston S; Green A; Mukhtar M; Agius L
    Biochem J; 2004 Jan; 377(Pt 1):195-204. PubMed ID: 13678417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased potency and efficacy of combined phosphorylase inactivation and glucokinase activation in control of hepatocyte glycogen metabolism.
    Hampson LJ; Agius L
    Diabetes; 2005 Mar; 54(3):617-23. PubMed ID: 15734835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
    Latsis T; Andersen B; Agius L
    Biochem J; 2002 Nov; 368(Pt 1):309-16. PubMed ID: 12186629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycogenic action of protein targeting to glycogen in hepatocytes involves multiple mechanisms including phosphorylase inactivation and glycogen synthase translocation.
    Green AR; Aiston S; Greenberg CC; Freeman S; Poucher SM; Brady MJ; Agius L
    J Biol Chem; 2004 Nov; 279(45):46474-82. PubMed ID: 15322104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glucose 6-phosphate in mediating the effects of glucokinase overexpression on hepatic glucose metabolism.
    Härndahl L; Schmoll D; Herling AW; Agius L
    FEBS J; 2006 Jan; 273(2):336-46. PubMed ID: 16403021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucokinase and molecular aspects of liver glycogen metabolism.
    Agius L
    Biochem J; 2008 Aug; 414(1):1-18. PubMed ID: 18651836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
    Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium's effects on rat liver glucose metabolism in vivo.
    Rodriguez-Gil JE; Fernández-Novell JM; Barberá A; Guinovart JJ
    Arch Biochem Biophys; 2000 Mar; 375(2):377-84. PubMed ID: 10700396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
    Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose 6-phosphate plays a central role in the regulation of glycogen synthesis in a glycogen-storing liver cell line.
    Mayer D; Letsch I
    Cell Biochem Funct; 1989 Oct; 7(4):243-56. PubMed ID: 2514049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis.
    Aiston S; Hampson L; Gómez-Foix AM; Guinovart JJ; Agius L
    J Biol Chem; 2001 Jun; 276(26):23858-66. PubMed ID: 11309391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle.
    Stephens TJ; Canny BJ; Snow RJ; McConell GK
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):419-23. PubMed ID: 15236627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accumulation of 2-deoxyglucose-6-phosphate activates glycogen synthase (and inactivates glycogen phosphorylase) in rat skeletal muscle.
    Bergamini E; Locci-Cubeddu T; Masiello P; Villa E
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2368-71. PubMed ID: 6802151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glycogen content in insulin resistance in human muscle cells.
    Litherland GJ; Morris NJ; Walker M; Yeaman SJ
    J Cell Physiol; 2007 May; 211(2):344-52. PubMed ID: 17167773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.
    Guigas B; Bertrand L; Taleux N; Foretz M; Wiernsperger N; Vertommen D; Andreelli F; Viollet B; Hue L
    Diabetes; 2006 Apr; 55(4):865-74. PubMed ID: 16567505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase.
    Gomis RR; Ferrer JC; Guinovart JJ
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):811-6. PubMed ID: 11042138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site.
    Hampson LJ; Arden C; Agius L; Ganotidis M; Kosmopoulou MN; Tiraidis C; Elemes Y; Sakarellos C; Leonidas DD; Oikonomakos NG
    Bioorg Med Chem; 2006 Dec; 14(23):7835-45. PubMed ID: 16908161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.